Stockreport

Why Esperion Therapeutics (ESPR) Is Up After $75M Equity Raise and Generic Settlement News [Yahoo! Finance]

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com
PDF stock at US$2.50 per share, raising total gross proceeds of approximately US$75 million to fund ongoing development and commercialization initiatives. This capital rai [Read more]